Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2968) 2968
Book Review (396) 396
Publication (204) 204
Book Chapter (9) 9
Book / eBook (5) 5
Conference Proceeding (5) 5
Newspaper Article (4) 4
Newsletter (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2838) 2838
humans (2806) 2806
female (2636) 2636
endometrial cancer (1249) 1249
endometrial neoplasms - pathology (1103) 1103
middle aged (1055) 1055
oncology (1015) 1015
cancer (992) 992
aged (824) 824
adult (748) 748
immunohistochemistry (696) 696
endometrial neoplasms - genetics (684) 684
biochemistry & molecular biology (608) 608
endometrial neoplasms - metabolism (578) 578
endometrial neoplasms - chemistry (552) 552
carcinoma (535) 535
expression (534) 534
animals (482) 482
cell line, tumor (469) 469
pathology (441) 441
breast-cancer (403) 403
endometrial carcinoma (389) 389
prognosis (389) 389
cell biology (384) 384
tumors (376) 376
obstetrics & gynecology (365) 365
aged, 80 and over (353) 353
endometrium (333) 333
gene expression regulation, neoplastic (316) 316
neoplasm staging (291) 291
research (289) 289
analysis (279) 279
male (274) 274
mutation (272) 272
apoptosis (271) 271
biomarkers, tumor - analysis (270) 270
gene expression (268) 268
genetic aspects (265) 265
adenocarcinoma (259) 259
mice (255) 255
tumor cells, cultured (255) 255
adenocarcinoma - pathology (246) 246
estrogen (246) 246
risk factors (243) 243
proteins (226) 226
breast cancer (225) 225
endometrial neoplasms - drug therapy (222) 222
ovarian cancer (214) 214
health aspects (213) 213
metastasis (213) 213
cells (195) 195
endocrinology & metabolism (183) 183
research article (178) 178
medicine (174) 174
cell proliferation (168) 168
polymerase chain reaction (168) 168
receptors, estrogen - analysis (168) 168
adenocarcinoma - chemistry (167) 167
article (163) 163
risk (160) 160
genes (158) 158
ovarian neoplasms - pathology (158) 158
care and treatment (157) 157
development and progression (157) 157
endometrium - pathology (156) 156
abridged index medicus (154) 154
neoplasm invasiveness (154) 154
survival (152) 152
genetics & heredity (150) 150
growth (146) 146
microsatellite instability (146) 146
signal transduction (145) 145
gene (143) 143
endometrial neoplasms - diagnosis (142) 142
physiological aspects (142) 142
cell proliferation - drug effects (141) 141
endometrium - chemistry (141) 141
prostate-cancer (141) 141
receptors, progesterone - analysis (141) 141
cancer research (137) 137
case-control studies (137) 137
diagnosis (136) 136
uterus (134) 134
women (134) 134
endometrium - metabolism (133) 133
gene-expression (131) 131
reverse transcriptase polymerase chain reaction (131) 131
adenocarcinoma - metabolism (126) 126
carcinoma, endometrioid - pathology (126) 126
p53 (126) 126
base sequence (124) 124
mutations (124) 124
endometrial neoplasms - mortality (123) 123
endometrial neoplasms - surgery (122) 122
rna, messenger - genetics (121) 121
blotting, western (120) 120
chemotherapy (120) 120
rna, messenger - metabolism (120) 120
breast neoplasms - metabolism (119) 119
ovarian-cancer (119) 119
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2892) 2892
Chinese (31) 31
Russian (22) 22
Japanese (7) 7
Polish (7) 7
French (6) 6
Czech (5) 5
Romanian (4) 4
Spanish (4) 4
Bulgarian (3) 3
German (2) 2
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast
by Ingeborg M. Bachmann and Ole J. Halvorsen and Karin Collett and Ingunn M. Stefansson and Oddbjørn Straume and Svein A. Haukaas and Helga B. Salvesen and Arie P. Otte and Lars A. Akslen
Journal of Clinical Oncology, ISSN 0732-183X, 01/2006, Volume 24, Issue 2, pp. 268 - 273
Purpose EZH2 is a member of the polycomb group of genes and important in cell cycle regulation. Increased expression of EZH2 has been associated previously... 
HISTOLOGICAL GRADE | PROGNOSTIC IMPACT | P16 PROTEIN EXPRESSION | GENE | ONCOLOGY | POOR-PROGNOSIS | COMPLEXES | TISSUE MICROARRAYS | CELL PROLIFERATION | POLYCOMB | CARCINOMA | Immunohistochemistry | Prostatic Neoplasms - chemistry | Cell Proliferation | Endometrial Neoplasms - mortality | Humans | Skin Neoplasms - chemistry | DNA-Binding Proteins - analysis | Male | Breast Neoplasms - chemistry | Skin Neoplasms - mortality | Female | Melanoma - chemistry | Skin Neoplasms - pathology | Prostatic Neoplasms - pathology | Endometrial Neoplasms - chemistry | Biomarkers, Tumor - analysis | Melanoma - pathology | Enhancer of Zeste Homolog 2 Protein | Prostatic Neoplasms - mortality | Polycomb Repressive Complex 2 | Ki-67 Antigen - analysis | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Endometrial Neoplasms - pathology | Transcription Factors - analysis | Melanoma - mortality | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text SMARCA4 (BRG1) Loss of Expression Is a Useful Marker for the Diagnosis of Ovarian Small Cell Carcinoma of the Hypercalcemic Type (Ovarian Rhabdoid Tumor): A Comprehensive Analysis of 116 Rare Gynecologic Tumors, 9 Soft Tissue Tumors, and 9 Melanomas
by Karanian-Philippe, Marie and Velasco, Valérie and Longy, Michel and Floquet, Anne and Arnould, Laurent and Coindre, Jean-Michel and Le Naoures-Méar, Cécile and Averous, Gerlinde and Guyon, Frédéric and MacGrogan, Gaëtan and Croce, Sabrina
The American Journal of Surgical Pathology, ISSN 0147-5185, 09/2015, Volume 39, Issue 9, pp. 1197 - 1205
Ovarian small cell carcinoma of the hypercalcemic type (SCCOHT)/ovarian rhabdoid tumor is a rare and highly malignant tumor that typically occurs in young... 
Rhabdoid tumor | Ovary | INI1/SMARCB1 | SMARCA4/BRG1 | Small cell carcinoma hypercalcemic type | SURGERY | SMARCB1 | FUSION | NEOPLASMS | BRG1 | PATHOLOGY | small cell carcinoma hypercalcemic type | SMARCA4 | INI1 | ovary | SARCOMAS | rhabdoid tumor | MUTATIONS | Immunohistochemistry | Predictive Value of Tests | Carcinoma, Small Cell - genetics | Nuclear Proteins - analysis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Sarcoma, Ewing - pathology | Granulosa Cell Tumor - pathology | Rhabdoid Tumor - pathology | Bone Neoplasms - pathology | Ovarian Neoplasms - genetics | Young Adult | Carcinoma, Small Cell - chemistry | Sarcoma, Endometrial Stromal - pathology | Soft Tissue Neoplasms - chemistry | Melanoma - genetics | Bone Neoplasms - chemistry | Adult | Female | Bone Neoplasms - genetics | Melanoma - chemistry | Soft Tissue Neoplasms - genetics | Hypercalcemia - genetics | Diagnosis, Differential | Ovarian Neoplasms - chemistry | Sarcoma, Ewing - chemistry | Hypercalcemia - pathology | Endometrial Neoplasms - chemistry | Biomarkers, Tumor - analysis | Rhabdoid Tumor - chemistry | Hypercalcemia - metabolism | Melanoma - pathology | Sarcoma, Endometrial Stromal - chemistry | Rhabdoid Tumor - genetics | Biopsy | Adolescent | Soft Tissue Neoplasms - pathology | DNA Helicases - analysis | Endometrial Neoplasms - pathology | Granulosa Cell Tumor - chemistry | Biomarkers, Tumor - genetics | Transcription Factors - analysis | Carcinoma, Small Cell - pathology | Neoplasm Staging | Sarcoma, Ewing - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms
by Tafe, Laura J and Garg, Karuna and Chew, Ivy and Tornos, Carmen and Soslow, Robert A
Modern Pathology, ISSN 0893-3952, 06/2010, Volume 23, Issue 6, pp. 781 - 789
Carcinomas of the endometrium and ovary with undifferentiated components are uncommon neoplasms that are likely underdiagnosed. They are important to recognize... 
Ovary | Undifferentiated carcinoma | Endometrioid carcinoma | Malignant mixed Mullerian tumor | DNA mismatch repair | Endometrium | undifferentiated carcinoma | ovary | MALIGNANT RHABDOID TUMOR | CARCINOSARCOMA | UTERUS | endometrium | malignant mixed Mullerian tumor | PATHOLOGY | endometrioid carcinoma | MORPHOLOGY | FEATURES | Immunohistochemistry | Predictive Value of Tests | Microsatellite Instability | Endometrial Neoplasms - mortality | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Carcinoma - mortality | Ovarian Neoplasms - mortality | Carcinoma - chemistry | Ovarian Neoplasms - genetics | Young Adult | Endometrial Neoplasms - genetics | Time Factors | DNA Mismatch Repair | Adult | Female | Cell Differentiation | Carcinoma - pathology | Carcinoma - secondary | Diagnosis, Differential | Ovarian Neoplasms - chemistry | Endometrial Neoplasms - chemistry | Biomarkers, Tumor - analysis | Neoplasm Invasiveness | Treatment Outcome | Lymphatic Metastasis | Endometrial Neoplasms - therapy | Ovarian Neoplasms - therapy | Carcinoma - genetics | Carcinoma - therapy | Endometrial Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Neoplasm Staging | Carcinoma, Endometrioid - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 Mutations
by Senter, Leigha and Clendenning, Mark and Sotamaa, Kaisa and Hampel, Heather and Green, Jane and Potter, John D and Lindblom, Annika and Lagerstedt, Kristina and Thibodeau, Stephen N and Lindor, Noralane M and Young, Joanne and Winship, Ingrid and Dowty, James G and White, Darren M and Hopper, John L and Baglietto, Laura and Jenkins, Mark A and de la Chapelle, Albert
Gastroenterology, ISSN 0016-5085, 2008, Volume 135, Issue 2, pp. 419 - 428.e1
Background & Aims: Although the clinical phenotype of Lynch syndrome (also known as hereditary nonpolyposis colorectal cancer) has been well described, little... 
Gastroenterology and Hepatology | BETHESDA GUIDELINES | COLON-CANCER | DNA MISMATCH REPAIR | CHILDHOOD-CANCER | NONPOLYPOSIS COLORECTAL-CANCER | MICROSATELLITE INSTABILITY | HETEROZYGOUS MUTATIONS | GASTROENTEROLOGY & HEPATOLOGY | CONSTITUTIVE DEFICIENCY | ENDOMETRIAL CANCER | GENE PMS2 | Immunohistochemistry | Colorectal Neoplasms - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - pathology | Humans | Middle Aged | DNA Repair Enzymes - genetics | Gene Expression Regulation, Neoplastic | Colorectal Neoplasms - chemistry | DNA-Binding Proteins - analysis | Male | DNA Mutational Analysis - methods | Endometrial Neoplasms - genetics | Ligase Chain Reaction | Adenosine Triphosphatases - analysis | Polymerase Chain Reaction | Germ-Line Mutation | Adult | Female | Mismatch Repair Endonuclease PMS2 | Odds Ratio | Endometrial Neoplasms - chemistry | Risk Assessment | Colorectal Neoplasms, Hereditary Nonpolyposis - genetics | Genotype | Penetrance | DNA-Binding Proteins - genetics | DNA Repair Enzymes - analysis | Phenotype | Proto-Oncogene Proteins B-raf - genetics | Endometrial Neoplasms - pathology | Heterozygote | Adenosine Triphosphatases - genetics | Aged | Colorectal Neoplasms, Hereditary Nonpolyposis - chemistry | Colorectal Neoplasms - pathology | Genetic aspects | Research | Oncology, Experimental | Colorectal cancer | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases
by Köbel, Martin and Meng, Bo and Hoang, Lien N and Almadani, Noorah and Li, Xiaodong and Soslow, Robert A and Gilks, C Blake and Lee, Cheng-Han
The American Journal of Surgical Pathology, ISSN 0147-5185, 02/2016, Volume 40, Issue 2, pp. 166 - 180
Mixed endometrial carcinoma refers to a tumor that comprises 2 or more distinct histotypes. We studied 18 mixed-type endometrial carcinomas—11 mixed serous and... 
Serous carcinoma | Endometrioid carcinoma clear cell carcinoma | Nextgeneration sequencing | Endometrial cancer | Mixed carcinoma | SURGERY | next-generation sequencing | P53 EXPRESSION | PROGNOSIS | endometrioid carcinoma clear cell carcinoma | ADENOCARCINOMAS | mixed carcinoma | CLASSIFICATION | PATHOLOGY | DEFICIENCY | UTERINE SEROUS CARCINOMA | endometrial cancer | DIAGNOSTIC UTILITY | OVARIAN | MUTATIONS | serous carcinoma | CLEAR-CELL CARCINOMA | Immunohistochemistry | Neoplasms, Complex and Mixed - genetics | Predictive Value of Tests | Alberta | Humans | Middle Aged | Carcinoma - chemistry | Neoplasms, Complex and Mixed - therapy | Molecular Diagnostic Techniques | Neoplasm Grading | Endometrial Neoplasms - genetics | Time Factors | DNA Mutational Analysis | Neoplasms, Complex and Mixed - diagnosis | Aged, 80 and over | Female | Carcinoma - pathology | Genetic Predisposition to Disease | Endometrial Neoplasms - chemistry | Biomarkers, Tumor - analysis | Carcinoma - diagnosis | Treatment Outcome | Endometrial Neoplasms - diagnosis | Neoplasms, Complex and Mixed - chemistry | Phenotype | Neoplasms, Complex and Mixed - pathology | Endometrial Neoplasms - therapy | Carcinoma - genetics | Carcinoma - therapy | Endometrial Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Mutation | Clonal Evolution | Evolution, Molecular | Index Medicus | next generation sequencing
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The Histomorphology of Lynch Syndrome–associated Ovarian Carcinomas: Toward a Subtype-specific Screening Strategy
by Chui, Michael Herman and Ryan, Paul and Radigan, Jordan and Ferguson, Sarah E and Pollett, Aaron and Aronson, Melyssa and Semotiuk, Kara and Holter, Spring and Sy, Keiyan and Kwon, Janice S and Soma, Anita and Singh, Naveena and Gallinger, Steven and Shaw, Patricia and Arseneau, Jocelyne and Foulkes, William D and Gilks, C Blake and Clarke, Blaise A
The American Journal of Surgical Pathology, ISSN 0147-5185, 09/2014, Volume 38, Issue 9, pp. 1173 - 1181
Women with Lynch syndrome (LS) are at increased risk for the development of epithelial ovarian cancer (OC). Analogous to previous studies on BRCA1/2 mutation... 
ovarian cancer | mismatch repair | Lynch syndrome | CELL-TYPE | SURGERY | RISKS | SYNCHRONOUS PRIMARY CANCERS | ENDOMETRIAL CARCINOMA | BRCA1 | PATHOLOGY | WOMEN | FREQUENCY | GENES | GYNECOLOGIC CANCERS | MUTATIONS | Colorectal Neoplasms, Hereditary Nonpolyposis - classification | Immunohistochemistry | Predictive Value of Tests | Microsatellite Instability | Carcinoma, Endometrioid - classification | Genetic Testing | Early Detection of Cancer - methods | Colorectal Neoplasms, Hereditary Nonpolyposis - pathology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Ovarian Neoplasms - genetics | Ovarian Neoplasms - classification | Carcinoma, Endometrioid - chemistry | Neoplasm Grading | DNA Mutational Analysis | DNA Mismatch Repair | Germ-Line Mutation | Adult | Female | Registries | Carcinoma, Endometrioid - genetics | Genetic Predisposition to Disease | Ovarian Neoplasms - chemistry | Colorectal Neoplasms, Hereditary Nonpolyposis - genetics | Heredity | BRCA1 Protein - genetics | Canada | Phenotype | Lymphocytes, Tumor-Infiltrating - pathology | Biopsy | Pedigree | Aged | Colorectal Neoplasms, Hereditary Nonpolyposis - chemistry | BRCA2 Protein - genetics | Carcinoma, Endometrioid - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Lynch Syndrome Screening Should Be Considered for All Patients With Newly Diagnosed Endometrial Cancer
by Mills, Anne M and Liou, Sofia and Ford, James M and Berek, Jonathan S and Pai, Reetesh K and Longacre, Teri A
The American Journal of Surgical Pathology, ISSN 0147-5185, 11/2014, Volume 38, Issue 11, pp. 1501 - 1509
Lynch syndrome (LS) is an autosomal dominant inherited disorder caused by germline mutations in DNA mismatch repair (MMR) genes. Mutation carriers are at... 
Microsatellite instability | Endometrial adenocarcinoma | Lynch syndrome | Mismatch-repair deficiency | SURGERY | mismatch-repair deficiency | microsatellite instability | NONPOLYPOSIS COLORECTAL-CANCER | REPAIR PROTEIN IMMUNOHISTOCHEMISTRY | RISK | GENE MUTATION | endometrial adenocarcinoma | PATHOLOGY | CLINICAL-CRITERIA | ACADEMIC-MEDICAL-CENTER | TUMOR MORPHOLOGY | GERMLINE MUTATIONS | GYNECOLOGIC CANCERS | Immunohistochemistry | MutL Protein Homolog 1 | Predictive Value of Tests | Microsatellite Instability | Biomarkers, Tumor - deficiency | Colorectal Neoplasms, Hereditary Nonpolyposis - pathology | Humans | Middle Aged | DNA Mismatch Repair - genetics | Mass Screening - methods | DNA-Binding Proteins - deficiency | Neoplasm Grading | Endometrial Neoplasms - genetics | DNA Mutational Analysis | MutS Homolog 2 Protein - deficiency | Nuclear Proteins - deficiency | Aged, 80 and over | Adult | Female | Mismatch Repair Endonuclease PMS2 | DNA Repair Enzymes - deficiency | Adenosine Triphosphatases - deficiency | Endometrial Neoplasms - chemistry | Risk Assessment | Colorectal Neoplasms, Hereditary Nonpolyposis - genetics | Risk Factors | California | Biopsy | Adaptor Proteins, Signal Transducing - deficiency | Endometrial Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - chemistry | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Combined microsatellite instability, MLH1 methylation analysis, and immunohistochemistry for Lynch syndrome screening in endometrial cancers from GOG210: An NRG Oncology and Gynecologic Oncology Group study
by Goodfellow, Paul J and Billingsley, Caroline C and Lankes, Heather A and Ali, Shamshad and Cohn, David E and Broaddus, Russell J and Ramirez, Nilsa and Pritchard, Colin C and Hampel, Heather and Chassen, Alexis S and Simmons, Luke V and Schmidt, Amy P and Gao, Feng and Brinton, Louise A and Backes, Floor and Landrum, Lisa M and Geller, Melissa A and DiSilvestro, Paul A and Pearl, Michael L and Lele, Shashikant B and Powell, Matthew A and Zaino, Richard J and Mutch, David
Journal of Clinical Oncology, ISSN 0732-183X, 12/2015, Volume 33, Issue 36, pp. 4301 - 4308
Purpose The best screening practice for Lynch syndrome (LS) in endometrial cancer (EC) remains unknown. We sought to determine whether tumor microsatellite... 
DNA MISMATCH REPAIR | WOMEN | GERMLINE MUTATION | ONCOLOGY | NONPOLYPOSIS COLORECTAL-CANCER | PERFORMANCE | RISK | PMS2 | MSH6 MUTATION | FAMILY-HISTORY | IDENTIFICATION | Immunohistochemistry | MutL Protein Homolog 1 | Predictive Value of Tests | Microsatellite Instability | Age Factors | Early Detection of Cancer - methods | Colorectal Neoplasms, Hereditary Nonpolyposis - pathology | Humans | Middle Aged | DNA Repair Enzymes - genetics | Gene Expression Regulation, Neoplastic | DNA Mismatch Repair - genetics | Genetic Testing - methods | Colorectal Neoplasms, Hereditary Nonpolyposis - prevention & control | DNA Methylation | Endometrial Neoplasms - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - diagnosis | Germ-Line Mutation | Adult | Female | Mismatch Repair Endonuclease PMS2 | Nuclear Proteins - genetics | Population Surveillance - methods | Early Detection of Cancer - standards | Endometrial Neoplasms - chemistry | Colorectal Neoplasms, Hereditary Nonpolyposis - genetics | MutS Homolog 2 Protein - genetics | DNA-Binding Proteins - genetics | Pedigree | Adaptor Proteins, Signal Transducing - genetics | Endometrial Neoplasms - pathology | Adenosine Triphosphatases - genetics | Aged | Index Medicus | Gync13 | ORIGINAL REPORTS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Synchronous and metachronous endocervical and ovarian neoplasms: Evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms
by Elishaev, Esther and Gilks, C. Blake and Miller, Dianne and Srodon, Monica and Kurman, Robert J and Ronnett, Brigitte M
American Journal of Surgical Pathology, ISSN 0147-5185, 03/2005, Volume 29, Issue 3, pp. 281 - 294
The vast majority of endocervical adenocarcinomas are high-risk human papillomavirus (HPV)-related neoplasms, characterized by p16 expression and frequent loss... 
Adenocarcinoma | Immunohistochemistry | Ovary | Human papillomavirus | Cervix | Metastases | SURGERY | cervix | PROGESTERONE-RECEPTORS | MUCINOUS ADENOCARCINOMA | adenocarcinoma | PATHOLOGY | HUMAN-PAPILLOMAVIRUS DNA | MICROINVASIVE ADENOCARCINOMA | STAGE-I ADENOCARCINOMA | LYMPH-NODE METASTASES | metastases | UTERINE CERVIX | ovary | GLANDULAR DYSPLASIA | human papillomavirus | ENDOMETRIAL ADENOCARCINOMAS | immunohistochemistry | EARLY INVASIVE ADENOCARCINOMA | Humans | Middle Aged | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Immunoenzyme Techniques | Papillomaviridae - genetics | Ovarian Neoplasms - secondary | Cyclin-Dependent Kinase Inhibitor p16 - analysis | In Situ Hybridization | Ovarian Neoplasms - virology | Polymerase Chain Reaction | Adult | Female | Neoplasms, Multiple Primary - virology | Adenocarcinoma - chemistry | Ovarian Neoplasms - chemistry | Biomarkers, Tumor - analysis | Papillomaviridae - isolation & purification | Neoplasms, Multiple Primary - pathology | Adenocarcinoma - secondary | Adenocarcinoma - virology | Neoplasm Metastasis - pathology | Uterine Cervical Neoplasms - virology | Neoplasms, Multiple Primary - chemistry | Uterine Cervical Neoplasms - chemistry | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Safety and antitumor activity of pembrolizumab in advanced programmed death ligand 1–positive endometrial cancer: Results from the KEYNOTE-028 study
by Ott, Patrick A and Bang, Yung-Jue and Berton-Rigaud, Dominique and Elez, Elena and Pishvaian, Michael J and Rugo, Hope S and Puzanov, Igor and Mehnert, Janice M and Aung, Kyaw L and Lopez, Juanita and Carrigan, Marion and Saraf, Sanatan and Chen, Mei and Soria, Jean-Charles
Journal of Clinical Oncology, ISSN 0732-183X, 08/2017, Volume 35, Issue 22, pp. 2535 - 2541
Purpose The multicohort phase Ib KEYNOTE-028 (NCT02054806) study was designed to evaluate the safety and efficacy of pembrolizumab, an anti-programmed death 1... 
CTLA-4 BLOCKADE | ONCOLOGY | TUMORS | PD-1 BLOCKADE | CHEMOTHERAPY | Microsatellite Instability | Humans | Middle Aged | Response Evaluation Criteria in Solid Tumors | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Fever - chemically induced | Carcinoma - chemistry | Endometrial Neoplasms - genetics | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Pruritus - chemically induced | Carcinoma - secondary | Carcinoma - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Endometrial Neoplasms - chemistry | Survival Rate | Disease-Free Survival | Retreatment | Anorexia - chemically induced | Carcinoma - genetics | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Aged | B7-H1 Antigen - analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation
by Zeimet, A.G and Reimer, D and Huszar, M and Winterhoff, B and Puistola, U and Azim, S.A and Muller-Holzner, E and Ben-Arie, A and Kempen, L.C.L.T. van and Petru, E and Jahn, S and Geels, Y.P and Massuger, L.F.A.G and Amant, F and Polterauer, S and Lappi-Blanco, E and Bulten, J and Meuter, A and Tanouye, S and Oppelt, P and Stroh-Weigert, M and Reinthaller, A and Mariani, A and Hackl, W and Netzer, M and Schirmer, U and Vergote, I and Altevogt, P and Marth, C and Fogel, M
Journal of the National Cancer Institute, ISSN 0027-8874, 2013, Volume 105, Issue 15, pp. 1142 - 1150
BACKGROUND: Despite the excellent prognosis of Federation Internationale de Gynecologie et d'Obstetrique (FIGO) stage I, type I endometrial cancers, a... 
ANTIBODIES | SURVIVAL | L1 EXPRESSION | IMPROVE | ADHESION MOLECULE | ONCOLOGY | SEROUS CARCINOMA | PROGNOSTIC-SIGNIFICANCE | PROGRESSION | CHEMOTHERAPY | UTERINE | Immunohistochemistry | Lymph Node Excision | Multivariate Analysis | Predictive Value of Tests | Endometrial Neoplasms - mortality | Humans | Middle Aged | Neoplasm Recurrence, Local - mortality | Sensitivity and Specificity | Adult | Female | Brachytherapy | Retrospective Studies | Radiotherapy, Adjuvant | Neural Cell Adhesion Molecule L1 - analysis | Endometrial Neoplasms - chemistry | Neoplasm Recurrence, Local - prevention & control | Ovariectomy | Risk Assessment | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Proportional Hazards Models | Neoplasm Recurrence, Local - diagnosis | Salpingectomy | Hysterectomy | Endometrial Neoplasms - diagnosis | Neoplasm Recurrence, Local - chemistry | Disease-Free Survival | Endometrial Neoplasms - therapy | Endometrial Neoplasms - pathology | Aged | Neoplasm Staging | Prognosis | Endometrial cancer | Physiological aspects | Genetic aspects | Research | Biological markers | Membrane proteins | Clinical trials | Womens health | Knowledge | Risk factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma
by Soovares, Piret and Pasanen, Annukka and Bützow, Ralf and Lassus, Heini
Gynecologic Oncology, ISSN 0090-8258, 2017, Volume 146, Issue 3, pp. 615 - 622
Highlights • L1CAM predicts poor outcome in endometrioid, but not in clear cell ovarian carcinoma. • Our findings are similar to those previously observed in... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Clear cell | Endometrioid | Response to therapy | Prognosis | L1CAM | Ovarian cancer | SURVIVAL | PREDICTOR | MARKER | CANCER | OBSTETRICS & GYNECOLOGY | THERAPY | ADHESION MOLECULE | ONCOLOGY | PROGRESSION | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Carcinoma, Endometrioid - therapy | Neoplasms, Multiple Primary - therapy | Carcinoma, Endometrioid - chemistry | Neoplasm Grading | Female | Neural Cell Adhesion Molecule L1 - analysis | Ovarian Neoplasms - chemistry | Endometrial Neoplasms - chemistry | Adenocarcinoma, Clear Cell - chemistry | Biomarkers, Tumor - analysis | Survival Rate | Treatment Outcome | Neoplasms, Multiple Primary - pathology | Disease-Free Survival | Adenocarcinoma, Clear Cell - therapy | Endometrial Neoplasms - therapy | Ovarian Neoplasms - therapy | Endometrial Neoplasms - pathology | Neoplasms, Multiple Primary - chemistry | Adenocarcinoma, Clear Cell - pathology | Neoplasm Staging | Carcinoma, Endometrioid - pathology | Carcinoma | Cancer | Medicine, Experimental | Medical research | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Immunohistochemical Profile of the Sodium/Iodide Symporter in Thyroid, Breast, and Other Carcinomas Using High Density Tissue Microarrays and Conventional Sections
by Wapnir, Irene L and van de Rijn, Matt and Nowels, Kent and Amenta, Peter S and Walton, Kelly and Montgomery, Kelli and Greco, Ralph S and Dohán, Orsolya and Carrasco, Nancy
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 04/2003, Volume 88, Issue 4, pp. 1880 - 1888
Extrathyroidal cancers could potentially be targeted with 131I, if the Na+/I− symporter (NIS) were functional. Using immunohistochemical methods we probed 1278... 
TRANSPORTER | RADIOIODINE THERAPY | CLONING | BENIGN | SODIUM-IODIDE SYMPORTER | PROSTATE-CANCER | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | NA+/I SYMPORTER | SALIVARY-GLAND | MAMMARY-GLAND | Immunohistochemistry | Ovarian Neoplasms - chemistry | Prostatic Neoplasms - chemistry | Endometrial Neoplasms - chemistry | Lung Neoplasms - chemistry | Humans | Thyroid Neoplasms - chemistry | Male | Thyroid Neoplasms - radiotherapy | Organ Specificity | Neoplasms - chemistry | Symporters - analysis | Breast Neoplasms - chemistry | Iodine Radioisotopes - therapeutic use | Colonic Neoplasms - chemistry | Female | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights